Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays

Cancer Biomarkers

Volumn 8, Issue 4-5, 2010, Pages 293-307

  Ramirez, Arturo B ^a   Lampe, Paul D ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

antibody microarray; biomarkers; Ovarian cancer

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CYTOKINE; INTERLEUKIN 1BETA; TUMOR MARKER;

ADULT; AGED; ANTIBODY MICROARRAY; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER IMMUNOLOGY; CANCER STAGING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; MEDICAL TECHNOLOGY; MICROARRAY ANALYSIS; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SERUM; VALIDATION PROCESS; WESTERN BLOTTING;

ANTIBODIES; ANTIGENS, NEOPLASM; FEMALE; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 81155132141     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2011-0215     Document Type: Article

References (35)

1. Cancer Facts and Figures for 2009. http://www.cancer.org/ docroot/STT/stt 0.asp.
2. P. Angenendt, J. Glokler, D. Murphy, H. Lehrach and D.J. Cahill, Toward optimized antibodymicroarrays: a comparison of current microarray support materials, Anal Biochem 309(2) Oct 15), 253-260.
3. E. Bereczki, S. Gonda, T. Csont, E. Korpos, A. Zvara, P. Ferdinandy and M. Santha, Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study, J Proteome Res 6(2) (Feb), 854-861.
4. B.B. Haab, M.J. Dunham and P.O. Brown, Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions, Genome Biol 2(2) RESEARCH0004.
5. B.B. Haab, Antibody arrays in cancer research, Mol Cell Proteomics 4(4)(Apr), 377-383.
6. S.T. Chari, C.L. Leibson, K.G. Rabe, J. Ransom, M. de Andrade and G.M. Petersen, Probability of pancreatic cancer following diabetes: a population-based study, Gastroenterology 129(2) (Aug), 504-511.
7. A. Vazquez-Martin, R. Colomer and J.A. Menendez, Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer, Eur J Cancer 43(7)(May), 1117-1124.
8. C.M. Loch, A.B. Ramirez, Y. Liu, C.L. Sather, J.J. Delrow, N. Scholler, B.M. Garvik, N.D. Urban, M.W. McIntosh and P.D. Lampe, Use of High Density Antibody Arrays to Validate and Discover Cancer SerumBiomarkers, Molecular Oncology 1(3), 313-320.
9. N. Scholler, J.A. Gross, B. Garvik, L. Wells, Y. Liu, C.M. Loch, A.B. Ramirez, M.W. McIntosh, P.D. Lampe and N. Urban, Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery, J Transl Med 6 41.
10. A.B. Ramirez, C.M. Loch, Y. Zhang, Y. Liu, X. Wang, E.A. Wayner, J. Sargent, S. Sibani, E.A. Mendoza, R. Eugene, J. LaBaer, N. Urban, M.W. McIntosh and P.D. Lampe, Use of a single chain antibody library for ovarian cancer biomarker discovery, Mol Cell Proteomics 9(7) (Jul), 1449-1460.
11. J.C. Miller, H. Zhou, J. Kwekel, R. Cavallo, J. Burke, E.B. Butler, B.S. Teh and B.B. Haab, Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers, Proteomics 3(1) (Jan), 56-63.
12. J. Ingvarsson, C.Wingren, A. Carlsson, P. Ellmark, B.Wahren, G. Engstrom, U.Harmenberg,M.Krogh, C. Peterson and C.A. Borrebaeck, Detection of pancreatic cancer using antibody microarray-based serum protein profiling, Proteomics 8(11) (Jun), 2211-2219.
13. S.L. Servoss, R. Gonzalez, S. Varnum and R.C. Zangar, Highthroughput analysis of serum antigens using sandwich ELISAs on microarrays, Methods Mol Biol 520, 143-150.
14. M.W. Shafer, L. Mangold, A.W. Partin and B.B. Haab, Antibody array profiling reveals serum TSP-1 as amarker to distinguish benign from malignant prostatic disease, Prostate 67(3) (Feb 15), 255-267.
15. W. Kusnezow, Y.V. Syagailo, S. Ruffer, N. Baudenstiel, C. Gauer, J.D. Hoheisel, D. Wild and I. Goychuk, Optimal design of microarray immunoassays to compensate for kinetic limitations: theory and experiment, Mol Cell Proteomics 5(9) (Sep), 1681-1696.
16. W.Kusnezowand J.D. Hoheisel, Solid supports formicroarray immunoassays, J Mol Recognit 16(4) (Jul-Aug), 165-176.
17. W. Kusnezow, A. Jacob, A. Walijew, F. Diehl and J.D. Hoheisel, Antibody microarrays: an evaluation of production parameters, Proteomics 3(3) (Mar), 254-264.
18. W. Kusnezow, V. Banzon, C. Schroder, R. Schaal, J.D. Hoheisel, S. Ruffer, P. Luft, A. Duschl and Y.V. Syagailo, Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies, Proteomics 7(11) (Jun), 1786-1799.
19. H. Zhou, K. Bouwman, M. Schotanus, C. Verweij, J.A. Marrero, D. Dillon, J. Costa, P. Lizardi and B.B. Haab, Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements, Genome Biol 5(4) R28.
20. R.Orchekowski, D.Hamelinck, L. Li, E.Gliwa,M. vanBrocklin, J.A. Marrero, G.F. Vande Woude, Z. Feng, R. Brand and B.B. Haab, Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer, Cancer Res 65(23) (Dec 1), 11193-11202.
21. W.M. Gao, R. Kuick, R.P. Orchekowski, D.E. Misek, J. Qiu, A.K. Greenberg, W.N. Rom, D.E. Brenner, G.S. Omenn, B.B. Haab and S.M. Hanash, Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis, BMC Cancer 5, 110.
22. I. Hellstrom, J. Raycraft, M. Hayden-Ledbetter, J.A. Ledbetter, M. Schummer, M. McIntosh, C. Drescher, N. Urban and K.E. Hellstrom, The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma, Cancer Res 63(13) (Jul 1), 3695-3700.
23. M.W. McIntosh, C. Drescher, B. Karlan, N. Scholler, N. Urban, K.E. Hellstrom and I. Hellstrom, Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma, Gynecol Oncol 95(1) (Oct), 9-15.
24. M.W. McIntosh, Y. Liu, C. Drescher, N. Urban and E.P. Diamandis, Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma, Clin Cancer Res 13(15 Pt 1) (Aug 1), 4422-4428.
25. G.K. Smyth and T. Speed, Normalization of cDNAmicroarray data, Methods 31(4) (Dec), 265-273.
26. G.K. Smyth, in: Limma: Linear Models for Microarray Data in Bioinformatics and Computational Biology Solutions using R and Bioconductor, R. Gentleman, V. Carey, S. Dudoit, R. Irizarry and W. Huber, eds, Springer, New York, 2005, pp. 397-420.
27. C. Palmer, X. Duan, S. Hawley, N. Scholler, J.D. Thorpe, R.A. Sahota, M.Q. Wong, A. Wray, L.A. Bergan, C.W. Drescher, M.W. McIntosh, P.O. Brown, B.H. Nelson and N. Urban, Systematic evaluation of candidate blood markers for detecting ovarian cancer, PLoS ONE 3(7), e2633.
28. Online Mendelian Inheritance in Men, http://www.ncbi.nlm. nih.gov/omim.
29. J. Yang, M. Boerm, M. McCarty, C. Bucana, I.J. Fidler, Y. Zhuang and B. Su, Mekk3 is essential for early embryonic cardiovascular development, NatGenet 24(3) (Mar), 309-313.
30. Uniprot search engine, http://www.uniprot.org/.
31. G.L.Wang, B.H. Jiang, E.A. Rue and G.L. Semenza, Hypoxiainducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc Natl Acad Sci U S A 92(12) (Jun 6), 5510-5514.
32. G.L. Semenza, HIF-1 and human disease: one highly involved factor, Genes Dev 14(16) (Aug 15), 1983-1991.
33. Genecards search engine, http://www.genecards.org/index. shtml.
34. Human Protein Atlas search engine, http://www.proteinatlas. org/index.php.
35. D. Hanahan and R.A.Weinberg, The hallmarks of cancer, Cel l100(1) (Jan 7), 57-70.